Elevance Health (ELV) Q2 2025 Earnings Call Transcript

Powered byQuartr

Company Participants

  • Operator
  • Nathan Rich - VP - IR, Elevance Health
  • Gail Boudreaux - President, CEO & Director, Elevance Health
  • Mark Kaye - EVP & CFO, Elevance Health
  • Andrew Mok - Director, Barclays
  • A.J. Rice - Managing Director, UBS Group
  • Stephen Baxter - Senior Equity Research Analyst, Wells Fargo
  • Lisa Gill - Managing Director, JP Morgan
  • Felicia Norwood - EVP & President - Government Health Benefits, Elevance Health
  • Lance Wilkes - Managing Director, Bernstein
  • Justin Lake - Analyst - Healthcare Services, Wolfe Research, LLC
  • Erin Wright. - Senior Healthcare Equity Research Analyst, Morgan Stanley
  • Ben Hendrix - Vice President, RBC Capital Markets
  • Joshua Raskin - Partner - Managed Care & Providers, Nephron Research LLC
  • Dave Windley - Managing Director, Jefferies LLC
  • Ann Hynes - MD & Senior Healthcare Services Equity Analyst, Mizuho Financial Group
  • Kevin Fischbeck - Director & Equity Research Analyst, Bank of America
  • Ryan Langston - Director & Senior Analyst - Healthcare Research, TD Cowen
  • Sarah James - MD, Equity Analyst-Healthcare Services & HCIT, Cantor Fitzgerald
  • Peter Haytaian - EVP, President - Carelon & CarelonRx, Elevance Health
  • George Hill - MD & Equity Research Analyst, Deutsche Bank
  • Jason Cassorla - Senior Equity Research Analyst, Guggenheim Partners
  • Whit Mayo - Senior Managing Director, Leerink Partners
  • Morgan Kendrick - EVP, President - Commercial & Specialty Health Benefits, Elevance Health
  • Michael Ha - Senior Research Analyst, Robert W. Baird & Co